The narrative around healthcare AI adoption tends to focus on implementation — the technical challenges of integration, the clinical validation of outputs, the workflow changes required to embed a new system into existing practice. These are real challenges. They are not, however, where most healthcare AI projects actually fail. Most healthcare AI projects fail before implementation begins — in the decisions made and not made during procurement, planning, and governance design.
Failure mode one: technology procured ahead of governance
The most common failure mode in healthcare AI adoption is procurement that precedes governance. An organisation identifies an AI tool that solves an apparent problem, obtains budget, and procures it. The governance questions — what is the intended purpose, who is accountable, how are outputs monitored, what is the escalation process — are addressed during implementation, if at all.
The problem with this sequence is that governance is much harder to retrofit than to design in advance. A system that has been deployed without a clear intended purpose definition is difficult to assess for MHRA classification. A workflow built around an AI output without human oversight mechanisms is difficult to modify once staff have adapted to it.
Technology procured ahead of governance does not fail at go-live. It fails six months later, when the governance questions that were deferred cannot be avoided any longer.
Failure mode two: data readiness assumed rather than assessed
AI systems are only as good as the data they operate on. Healthcare organisations that adopt AI tools frequently discover, during or after implementation, that their data does not support the use case they have purchased the system for. The most common data readiness failures include: data that is inconsistently structured across sites; information governance frameworks that do not permit the required data flows; data quality issues not surfaced during vendor demonstrations; and patient consent frameworks not designed with AI data use in mind.
These problems are discoverable before procurement. They require a structured data readiness assessment — an honest evaluation of what data exists, in what quality, with what governance, and whether it supports the intended AI use case. Most organisations do not conduct one.
Failure mode three: staff preparation treated as training rather than change
AI implementation programmes consistently underestimate the human change required for successful adoption. A clinician who is not clear about their responsibility for reviewing and validating AI-generated content is a governance risk, not an implementation problem. Effective AI adoption requires staff to understand not just how to use the system, but what it is, what it is not, and what their responsibility is at every point where they interact with its outputs.
Failure mode four: vendor assessment treated as independent governance review
AI vendors conduct assessments of their own products. These assessments are useful for understanding what a system does and how it has been validated. They are not substitutes for independent governance review. An organisation that relies on vendor-supplied clinical validation and vendor-recommended implementation frameworks is outsourcing its governance to an entity with a commercial interest in the system's adoption.
The preventable pattern
Each of these failure modes is preventable. What they require is a different sequence — governance assessment and readiness work conducted before procurement, not during implementation or after go-live. Novatib's AI Readiness & Governance Assessment is structured around preventing these specific failures.
This article reflects Novatib's advisory perspective based on observed patterns in healthcare AI adoption. It does not constitute legal or regulatory advice.